GWM
COLL icon

Gilpin Wealth Management’s Collegium Pharmaceutical COLL Stock Holding History

Gilpin Wealth Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$181 Hold
5
– – ﹤0.01% 939
2026
Q1 		$166 Hold
5
– – ﹤0.01% 892
2025
Q4 		$232 Buy
+5
New +$209 ﹤0.01% 619

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Gilpin Wealth Management's COLL Position: Q2 2026 in Review

Gilpin Wealth Management held its Collegium Pharmaceutical (COLL) position steady in Q2 2026 at 5 shares worth $181. The position accounts for ﹤0.01% of the portfolio, ranked #939.

Gilpin Wealth Management first reported a position in COLL in Q4 2025 and has held it in 3 quarters since. The position peaked at $232 in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Gilpin Wealth Management held 5 shares of Collegium Pharmaceutical worth $181 as of Q2 2026.
  • Gilpin Wealth Management left its Collegium Pharmaceutical share count unchanged in Q2 2026.
  • Collegium Pharmaceutical made up ﹤0.01% of Gilpin Wealth Management's portfolio in Q2 2026, its #939 holding.
  • Gilpin Wealth Management first reported a position in Collegium Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • Gilpin Wealth Management's Collegium Pharmaceutical position peaked at $232 in Q4 2025.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Gilpin Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.